Antipyrine metabolite formation in children in the acute phase of malnutrition and after recovery
- PMID: 7448107
- PMCID: PMC1430089
- DOI: 10.1111/j.1365-2125.1980.tb01772.x
Antipyrine metabolite formation in children in the acute phase of malnutrition and after recovery
Abstract
1. The plasma elimination rate of antipyrine and the urinary excretion of antipyrine and its primary metabolites 4-hydroxy-antipyrine, norantipyrine, 3-hydroxymethyl-antipyrine and 3-carboxyantipyrine were measured in five children in the acute phase of malnutrition and after recovery. The results were compared with those obtained in 3 normal children. 2. Upon nutritional rehabilitation antipyrine clearance increased from 0.65 +/- 0.14 ml min-1 kg-1 to 1.07 +/- 0.20 ml min-1 kg-1. 3. The urinary excretion of 4-hydroxy-antipyrine increased from 6.1 +/- 4.5 to 14.7 +/- 5.9%, norantipyrine from 8.8 +/- 5.7 to 14.3 +/- 5.4 and 3-hydroxy-methyl-antipyrine from 11.8 +/- 8.3 to 20.5 +/- 5.6% (% of dose/24h urine). Excretion of unchanged antipyrine decreased from 5.2 +/- 3.7 to 2.7 +/- 0.9% dose. The metabolite profile (ratio between the amounts of the various metabolites excreted) was not significantly different. 4. It is concluded that malnutrition decreases the rate of antipyrine metabolism, but it does not affect the three oxidative pathways differently.
Similar articles
-
Antipyrine pharmacokinetics and D-glucaric excretion in kwashiorkor.Am J Clin Nutr. 1979 Dec;32(12):2439-42. doi: 10.1093/ajcn/32.12.2439. Am J Clin Nutr. 1979. PMID: 506967
-
High-performance liquid chromatographic method for the determination of the three main oxidative and 3-carboxylic antipyrine metabolites in human urine.J Chromatogr. 1991 Jan 18;563(1):103-13. doi: 10.1016/0378-4347(91)80281-g. J Chromatogr. 1991. PMID: 2061375
-
Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment.Xenobiotica. 1979 Nov;9(11):695-702. doi: 10.3109/00498257909042337. Xenobiotica. 1979. PMID: 119355
-
Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time.Eur J Clin Pharmacol. 1982;21(5):433-41. doi: 10.1007/BF00542332. Eur J Clin Pharmacol. 1982. PMID: 7075648
-
Therapeutic Properties of Antipyrine.Daniels Tex Med J. 1887 Mar;2(9):371-372. Daniels Tex Med J. 1887. PMID: 36952804 Free PMC article. Review. No abstract available.
Cited by
-
Antipyrine clearance and metabolite formation in children with congenital adrenal hyperplasia.Br J Clin Pharmacol. 1985 Dec;20(6):703-6. doi: 10.1111/j.1365-2125.1985.tb05134.x. Br J Clin Pharmacol. 1985. PMID: 4092001 Free PMC article.
-
Drug metabolism and pharmacokinetics in malnourished children.Clin Pharmacokinet. 1989;17 Suppl 1:68-88. doi: 10.2165/00003088-198900171-00006. Clin Pharmacokinet. 1989. PMID: 2692941 Review.
-
Chloroquine kinetics in the undernourished.Eur J Clin Pharmacol. 1983;24(2):273-6. doi: 10.1007/BF00613831. Eur J Clin Pharmacol. 1983. PMID: 6840179
-
The effect of obesity, macronutrients, fasting and nutritional status on drug-metabolizing cytochrome P450s: a systematic review of current evidence on human studies.Eur J Nutr. 2021 Sep;60(6):2905-2921. doi: 10.1007/s00394-020-02421-y. Epub 2020 Nov 3. Eur J Nutr. 2021. PMID: 33141242
-
Dietary influences on the kinetics of antipyrine and aminopyrine in human subjects.Br J Clin Pharmacol. 1984 Feb;17(2):139-46. doi: 10.1111/j.1365-2125.1984.tb02328.x. Br J Clin Pharmacol. 1984. PMID: 6704283 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous